Your partner in shaping the future of molecular pathology

Your partner in shaping the future of molecular pathology

Your partner in shaping the future of molecular pathology

In-booth talk schedule

We have an exciting line-up of booth talks throughout AMP, including encore presentations of our corporate workshops. Check out the schedule and plan your visit. Click on each session title to learn more.

Thursday, November 7

12:00 p.m. How to rapidly go from 100,000 variants to clinically actionable insights

Speakers: Lisa Laing, PhD (QIAGEN) and  Jim Hayes, PhD (QIAGEN)

2:00 p.m. The magic is inside: Nanoplate-based digital PCR system

Speaker: Laima Antanaviciute, PhD (QIAGEN)

2:45 p.m. Detection of respiratory pathogens using the QIAstat-Dx Respiratory Panel

Speaker: Utsav Pandey, PhD (Children's Hospital, Los Angeles)

3:00 p.m. Reinventing targeted sequencing with QIAseq Multimodal: simultaneous DNA and RNA enrichment from one sample using a single-day workflow with integrated analysis for comprehensive tumor profiling

Speaker: Raed Samara, PhD (QIAGEN)

Friday, November 8

9:45 a.m. Detection of respiratory pathogen using the QIAstat-Dx Respiratory Panel

Speaker: Utsav Pandey, PhD (Children's Hospital, Los Angeles)

12:00 p.m. How to rapidly go from 100,000 variants to clinically actionable insights

Speakers: Lisa Laing, PhD (QIAGEN) and  Jim Hayes, PhD (QIAGEN)

12:15 p.m. The magic is inside: Nanoplate-based digital PCR system

Speaker: Laima Antanaviciute, PhD (QIAGEN)

12:45 p.m. Reinventing targeted sequencing with QIAseq Multimodal: simultaneous DNA and RNA enrichment from one sample using a single-day workflow with integrated analysis for comprehensive tumor profiling

Speaker: Raed Samara PhD (QIAGEN)

1:00 p.m. The power of one: QIAseq Multimodal’s one-day workflow consolidates DNA variant and RNA fusion analysis, from Sample to Insight

Speaker: Jonathan M. Shaffer, PhD (QIAGEN)

3:00 p.m. QIAGEN’s NGS System workflow in testing complex myeloid and lung cancer samples

Speakers: Ravindra Kolhe, PhD, MD (Georgia Esoteric & Molecular Laboratory at Augusta University)

Peter Wild, PhD (Senckenberg Institute for Pathology, University Hospital, Frankfurt, Germany

Next-Generation Sequencing (NGS) is becoming widely used for biomarker detection in Myeloid leukemia and Lung cancer samples, allowing testing of multiple markers at the same time. We will explore how 2x pre-optimized assays on the GeneReader NGS system have allowed laboratories to detect and call challenging variants in Myeloid and Lung cancer. The QIAGEN GeneReader NGS System, using the QIAact Myeloid DNA UMI panel and a custom Lung cancer assay, offers a complete Sample to Insight solution including bioinformatics tailored and optimized for the panel’s analysis and reporting, using QCI Analyze and QCI Interpret.

The GeneReader NGS System is for research use only. Not for use in diagnostic procedures.

3:30 p.m. The magic is inside: Nanoplate-based digital PCR system

Speaker: Michael Bussmann, PhD (QIAGEN)

Saturday, November 9

10:00 a.m. The magic is inside: Nanoplate-based digital PCR system

Speaker: Laima Antanaviciute, PhD

12:15 p.m. How to rapidly go from 100,000 variants to clinically actionable insights

Speakers: Lisa Laing, PhD and  Jim Hayes, PhD

Social Sharing